# A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

> **NCT03726866** · PHASE1 · UNKNOWN · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 30 (estimated)

## Conditions studied

- Dyslipidemias
- Hypertension

## Interventions

- **DRUG:** Sequence 1
- **DRUG:** Sequence 2
- **DRUG:** Sequence 3
- **DRUG:** Sequence 4
- **DRUG:** Sequence 5
- **DRUG:** Sequence 6

## Key facts

- **NCT ID:** NCT03726866
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-31
- **Primary completion:** 2019-01-15
- **Final completion:** 2019-01-15
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03726866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03726866, "A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03726866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*